Evidence map›Paper›PMID 31296230›Full record

ReviewJournal of hematology & oncology2019

K

A P Garneau, S Slimani, L E Tremblay, M J Fiola, A A Marcoux, P Isenring

Open access · goldAbstract readReview
In one paragraph

Review in Journal of hematology & oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Frontiers in cell and developmental biology · 2026
    Article
  5. Advances in Protein and Polypeptide Drug Analytics.Current pharmaceutical design · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. The Important Role of Ion Transport System in Cervical Cancer.International journal of molecular sciences · 2021
    Review
  15. Review
  16. Molecular characteristics and physiological roles of NaJournal of cellular physiology · 2021
    Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

A P GarneauFrom the Nephrology Research Group, Department of Medicine, Laval University, 11, côte du Palais, Québec (Qc), G1R 2J6, Canada.
S SlimaniFrom the Nephrology Research Group, Department of Medicine, Laval University, 11, côte du Palais, Québec (Qc), G1R 2J6, Canada.
L E TremblayFrom the Nephrology Research Group, Department of Medicine, Laval University, 11, côte du Palais, Québec (Qc), G1R 2J6, Canada.
M J FiolaFrom the Nephrology Research Group, Department of Medicine, Laval University, 11, côte du Palais, Québec (Qc), G1R 2J6, Canada.
A A MarcouxFrom the Nephrology Research Group, Department of Medicine, Laval University, 11, côte du Palais, Québec (Qc), G1R 2J6, Canada.
P IsenringFrom the Nephrology Research Group, Department of Medicine, Laval University, 11, côte du Palais, Québec (Qc), G1R 2J6, Canada. paul.isenring@crhdq.ulaval.ca.
Université Laval · CAHôtel-Dieu de Québec · CA

Funding

CIHR
6 · The paper itself

Abstract

During the 1970s, a Na

Indexed as

HematopoiesisAnimalsHumansK Cl- CotransportersNeoplasmsProtein IsoformsSymportersK Cl- CotransportersProtein IsoformsSymportersAbnormal cell growthAnimal modelsCation-Cl− cotransporterK+-Cl− cotransporterRed blood cellsSickle cell anemiaSubmitted to Journal of Hematology and Oncology

Identifiers

PMID31296230
PMCPMC6624878
OpenAlexW2960151143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.